End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.2 USD | -6.58% | -6.58% | -19.77% |
02:38pm | Bristol Myers: positive results in liver cancer | CF |
Jun. 03 | Bristol-Myers Squibb Says Breyanzi Studies Show 'Meaningful' Outcomes Across B-cell Malignancies | MT |
Financials (USD)
Sales 2024 * | 46.09B | Sales 2025 * | 46.06B | Capitalization | 84.67B |
---|---|---|---|---|---|
Net income 2024 * | -5.41B | Net income 2025 * | 10.22B | EV / Sales 2024 * | 2.68 x |
Net Debt 2024 * | 39.03B | Net Debt 2025 * | 31.68B | EV / Sales 2025 * | 2.53 x |
P/E ratio 2024 * |
-15.9
x | P/E ratio 2025 * |
7.9
x | Employees | 34,100 |
Yield 2024 * |
5.76% | Yield 2025 * |
6.05% | Free-Float | 69.27% |
Latest transcript on Bristol-Myers Squibb Company
1 day | +2.12% | ||
1 week | -6.58% | ||
1 month | -7.99% | ||
3 months | -16.63% | ||
6 months | -43.33% | ||
Current year | -19.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Date | Price | Change |
---|---|---|
24-06-03 | 41.2 | -.--% |
24-05-31 | 41.2 | -6.58% |
24-05-30 | 44.1 | -.--% |
24-05-29 | 44.1 | -.--% |
24-05-28 | 44.1 | -.--% |
End-of-day quote Lima, May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.60% | 748B | |
+33.78% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+17.17% | 245B | |
+9.39% | 211B | |
-3.76% | 209B | |
+1.81% | 166B |
- Stock Market
- Equities
- BMY Stock
- BMY Stock